DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

Horizon Pharma, Inc. (NASDAQ: HZNP)

12.34 -0.21 (-1.67%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

HZNP $12.34 -1.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.50
Previous Close $12.55
Daily Range $12.11 - $12.63
52-Week Range $3.70 - $18.30
Market Cap $922.7M
P/E Ratio -2.50
Dividend (Yield) $0.00 (0.0%)
Volume 1,507,791
Average Daily Volume 1,966,814
Current FY EPS $0.80

Sector

Healthcare

Industry

Drugs

Horizon Pharma, Inc. (HZNP) Description

Horizon Pharma Inc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis pain and inflammatory diseases. Website: http://www.horizonpharma.com/

News & Commentary Rss Feed

Monday’s Top Health Care Stories: AcelRx, Horizon Pharma, Hospira, GSK

AcelRx, Horizon Pharma, Hospira, GSK are the top health care stocks to watch this Monday morning.

POZEN Announces Receipt Of Three Patents From The United States Patent And Trademark Office

Update: Horizon Pharma Acquires U.S. Rights For Pennsaid 2%, Long Case Strengthens

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

Sector Update: Smaller Rise for Health Care Stocks Today; Horizon Pharma Turns Lower Despite Positiv

Sector Update: Smaller Rise for Health Care Stocks Today; Horizon Pharma Turns Lower Despite Positive Test for New Actimmune Use

Sector Update: Health Care

Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data, Says Results Show Statistical Signific

Horzion Pharma Presents Results of ACTIMMUNE(R) Phase 2 Data, Says Results Show Statistical Significant

Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog

3 Best Performing Stocks in September - Analyst Blog

3 Best Performing Stocks in September - Analyst Blog

Retrophin: Additional Red Flags Signal Extreme Caution For Investors

See More HZNP News...